Latest market price
254.50
-3.48-1.35%
OverviewShort InterestFilings
BBHVanEck Biotech ETF·NASDAQ
254.50-1.35%
TA
Loading chart...
Screen all →
VXUS+0.27%$82.59VUG-1.21%$84.03VTV+0.24%$228.57VO+0.25%$81.66VGT-2.68%$113.83VB+0.60%$291.80VWO+0.34%$55.70VIG+0.19%$248.24
Fund Snapshot
Category—Asset TypeEquityTagshealthcareReturn% 1Y41.21%Total Holdings25Perf Week2.87%
SponsorVanEckETF TypeTagssectorReturn% 3Y21.62%AUM$522.74MPerf Month7.18%
Fund FamilyBond TypeTags—Return% 5Y5.42%NAV/shPerf Quarter22.34%
Index—Average MaturityTags—Return% 10Y52W High262.60 -3.08%Perf Half Y37.12%
Index WeightingCommodity TypeTags—Return% SI52W Low177.35 43.50%Perf YTD34.47%
Active/PassiveQuant TypeTags—Flows% 1M6.23%Volatility2.17% 2.00%Perf Year42.91%
Dividend TTM0.96 (0.38%)ESG TypeTags—Flows% 3M7.28%ATR (14)4.80Perf 3Y72.65%
Dividend Ex-DateDec 22, 2025Dividend TypeSector/ThemeFlows% YTD8.08%RSI (14)61.76Perf 5Y27.30%
Dividend Gr. 3/5Y—Structure TypeRegionFlows% 1YBeta0.69Perf 10Y138.21%
Expense0.35%Growth/ValueSMA203.71%Flows% 3YRel Volume2.04Prev Close257.98
Inverse/LeveragedMarket CapSMA505.48%Flows% 5YAvg Volume11.58KPrice254.50
IPO DateDec 20, 2011Option/ShortYes / YesSMA20022.94%52W Range %90%Volume23,634Change-1.35%
Holdings Breakdown
View Holdings as
Stocks
99.9%Healthcare
0.1%Energy
Assets Under Management
0150.00M300.00M450.00M600.00MAprJunAugOct'25MarMayJulSepNov'26MarMayJulSepNov
● Assets Under Management
Latest News· Times ET
Oct-28-26
Oct-28-2612:11PM
ETFs That You May Consider Amid a Strengthening Biotech Outlookzacks.com
Oct-23-26
Oct-23-2609:01AM
Why Healthcare ETFs Are Hovering Around One-Year Highszacks.com
02:23AM
Reported October 22, U.S. Treasury Department Issues Notice Of Proposed Rulemaking For The Outbound Investment Security Program Under The COINS Act; Secretary Has Added Biotechnology To Proposed RegulationsBenzinga
Oct-22-26
Oct-22-2605:30AM
Biotech Giants vs. Emerging Innovators: Which ETF Is the Better Buy?fool.com
Oct-21-26
Oct-21-2607:01AM
Biotech ETF (BBH) Hits New 52-Week Highzacks.com
Oct-12-26
Oct-12-2604:00PM
BBH Capital Partners Private Equity Exits The Granite Groupbusinesswire.com
Oct-10-26
Oct-10-2602:47PM
Better Biotechnology ETF: First Trust FBT vs. VanEck BBHfool.com
12:19PM
Better Healthcare ETF: VanEck's Biotech-Focused BBH vs. State Street's XPH Targeting Pharmafool.com
Oct-07-26
Oct-07-2609:10AM
Market Concentration: Building For More Than One OutcomeSeekingAlpha
Oct-02-26
Oct-02-2608:40AM
Equity Outlook: AI, Higher Rates Raise The Bar For DiversificationSeekingAlpha
Sep-26-26
Sep-26-2607:37AM
David Rubenstein, Co-Founder Of The Carlyle Group, On The Business Of Sports, Investing And LeadershipSeekingAlpha
Sep-24-26
Sep-24-2610:42AM
Fidelity Healthcare ETF (FHLC) vs. VanEck Biotech ETF (BBH): Which Fund Is the Better Buy?fool.com
Sep-21-26
Sep-21-2601:05PM
Biotech ETFs to Buy as Cancer Drug Breakthroughs Acceleratezacks.com
Sep-18-26
Sep-18-2605:22AM
5 Undervalued Oncology Stocks Wall Street Is OverlookingSeekingAlpha
Sep-16-26
Sep-16-2607:21AM
Should You Invest in the VanEck Biotech ETF (BBH)?zacks.com
Fund

The VanEck Biotech ETF (BBH) aims to closely reflect the price appreciation and income yield of the MVIS US Listed Biotech 25 Index (MVBBHTR), prior to the deduction of fees and expenses. This index monitors the aggregate performance of corporations involved in the research, manufacturing, promotion, and sale of medications derived from genetic insights and diagnostic technologies.

Ownership

Per-holder 13F data isn't yet ingested for ETFs — coming with the next data layer expansion.

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR